PALM BEACH, Florida, February 7, 2017 /PRNewswire/ --
The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry
climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet
of the industry. The synergy created between modern technology and the explosive cannabis industry is allowing leaders in
marijuana to leverage consumer technology engagement for companies such as Reliq Health Technologies Inc. (OTC: RQHTF) (TSX-V:
RHT), Acology Inc. (OTC: ACOL), Cannabis Science, Inc. (OTC: CBIS), Lifestyle Delivery Systems Inc (OTC: LDSYF) and mCig, Inc.,
(OTC: MCIG)
Reliq Health Technologies Inc. (OTCQB: RQHTF) (RHT.V), is pleased to announce that it has entered into a Memorandum of
Understanding (MOU) with Invictus MD Strategies Corp. (IMH.V on the CSE exchange and also trading on the OTC Markets under the
symbol: IVITF;) ("Invictus MD") to develop a mobile application for cannabis patients and consumers and their clinical care
teams. Reliq Health, a healthcare technology company focused on developing innovative mobile health and telemedicine solutions,
has developed a novel SaaS (software as a service) solution for the community health care market. The solution provides automated
remote patient monitoring in the home and secure cloud-based communication, care planning and collaboration for all members of
the patient's circle of care. Reliq's secure platform allows clinicians to collect comprehensive data on patients' clinical
conditions, medication usage, symptoms, side effects and behaviours - creating a wealth of population health data. Read this full
release and recent news releases for Reliq Health Technologies at http://marketnewsupdates.com/news/rqhtf.html.
"Studies consistently show that providing patients with the tools they need for self-management of their health conditions
produces better health outcomes and reduces healthcare costs. Cannabis is prescribed to treat a wide range of conditions
including arthritis, glaucoma, side effects from chemotherapy, chronic pain, multiple sclerosis and post-traumatic stress
disorder. Our cannabis app allows patients to track usage and record symptoms specific to their clinical condition,
allowing patients and their care providers to determine optimum strain, dosing and mode of administration. Our platform will
improve access to care by connecting patients with physicians in their community who have experience with medical marijuana, and
supports physician-approved automated prescription refills through participating producers," said Dr. Lisa Crossley, CEO of Reliq.
Invictus MD's Chairman and CEO, Dan Kriznic, said, "Our wholly owned subsidiary: Poda
Technologies Ltd. ("Poda") is set for a launch in Q2 2017 of its Poda Pod vaporizer product which will provide an effective,
reliable and convenient way to vaporize cannabis that is designed to appeal to modern retail and medical consumers." The Poda Pod
vaporizer product, made with medical-grade components, has been designed to connect to users' smartphones via Bluetooth to
provide real-time information about dosage, product characteristics, track remaining contents, find vendors nearby, and customize
their experience. Agreements are being negotiated to license the PODA products to the Access to Cannabis for Medical Purposes
Regulations ("ACMPR") and licensed producers in Canada, helping those producers better reach and
serve consumers with convenient, refillable devices.
In other cannabis and medical marijuana sector related performance and announcements in
markets of note:
Acology Inc. (OTC: ACOL) closed up over 13% on Monday trading big volume of over 77.8 Million shares by the market
close. Acology announced on Monday that January was the biggest sales month in company history, shattering previous marks
achieved during the last quarter of 2016. Acology executives have expressed strong confidence that the first quarter of 2017
would continue this trend, basing their optimism on continued expansion in Canada and the
addition of new, complimentary products and product lines. Company income rose 33% above the same period last year. Unit sales of
all products, led by Acology's signature product, the MedTainer™, increased by 25% over last year.
Cannabis Science, Inc. (OTC: CBIS) closed up slightly on Monday trading over 21.8 Million shares by the market
close. Cannabis Science, together with its subsidiaries, develops, produces, and commercializes phyto cannabinoid-based
pharmaceutical products primarily in the United States. The company is involved in developing
medicines for autism, blood pressure, cancer and cancer side effects, as well as for other illnesses comprising for general
health maintenance.
Lifestyle Delivery Systems Inc (OTCQB: LDSYF) closed up over 12% at $0.5752 on Monday
trading over 800,000 shares by the market close. Lifestyle Delivery Systems produces and sells cannabis infused strips. It
develops and licenses a proprietary filmstrip technology that can be used to produce oral delivery systems for energy elixirs,
herbal remedies, and a smokeless alternative option to medical and recreational users of cannabis
mCig, Inc., (OTCQB: MCIG), a diversified company servicing the legal cannabis, hemp, and CBD markets announced on
Monday its preliminary earnings and financial results for its third quarter for FY 2017, ending January
31, 2017. MCIG generated $1.3M in revenue through its construction, CBD, and e-Cig divisions
during the third quarter bringing its total revenue for the FY to $2.2M. The revenue generated
represents a 546% increase from the same period last year, and a 204% increase from last quarter. MCIG's net income for the
quarter was $898K (with a $118K adjusted net income) bringing its
total net income YTD to $716K ($227K adjusted net income), a 32% net
margin. The company generated $341K in cash from operations and has increased its cash, and cash
equivalents, position by 311% this fiscal year to $420K. MCIG reports $1.26M in current assets with only $287K in current liabilities giving it an acid
test ratio of 4.3:1, its highest rating in company history.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates
electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company
mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's
market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research
material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. All material included herein is republished content and details
which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by
its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in
stocks. For current services performed MNU has been compensated three thousand nine hundred dollars
for news coverage of the current press release issued by Reliq Health Technologies Inc. by a non-affiliated third party. MNU
HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future
expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned",
"will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially
from those projected in the forward-looking statements, including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should
consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to
update such statements.
Contact Information:
Media Contact email:
info@marketnewsupdates.com
+1(561)325-8757